MDLN
Medline Inc.
Set alert
- YTD
- -23.52%
- 1 year
- -21.66%
- Open
- 31.93
- Prev close
- 32.00
- Mkt cap
- 43.22B
- Vol
- 14.57M
- Avg vol
- 8.39M
- EPS
- 0.40
- P/E
- 80.30
- Div yield
- 0.00%
More statistics
- Low
- 31.37
- High
- 32.32
- Forward P/E
- 20.46
- Beta
- 0.00
- Short ratio
- 4.51
- Inst. own
- 112.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 34.52
- 200-d avg
- 39.70
- 1y target
- 44.31
Key statistics
- Market cap
- 43.22B
- Enterprise value
- 45.52B
- Trailing P/E
- 80.30
- Forward P/E
- 20.46
- PEG ratio
- 0.00
- Price / sales
- 1.44
- Price / book
- 2.43
- EPS (TTM)
- 0.40
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 2.31%
- Revenue (TTM)
- 29.94B
- Revenue growth
- 11.60%
- Free cash flow
- 850.63M
- Total cash
- 2.70B
- Total debt
- 12.64B
- Return on equity
- 4.93%
- Shares outstanding
- 877.35M
- Short % of float
- 9.69%
- 50-day average
- 34.52
- 200-day average
- 39.70
Analyst view
Consensus: buy
- Target (low)
- 34.00
- Target (mean)
- 44.31
- Target (high)
- 55.00
- Strong buy7
- Buy16
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.3463.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 27, 2026 | 0.343 | — | — | — |
| Aug 5, 2026 | Jun 27, 2026 | 0.3524 | 0.50 | +0.15 | +41.88% |
| May 6, 2026 | Mar 31, 2026 | 0.2952 | 0.33 | +0.03 | +11.79% |
| Feb 25, 2026 | Dec 31, 2025 | 0.2381 | 0.2247 | -0.01 | -5.63% |
| Nov 4, 2025 | Sep 30, 2025 | — | 0.31 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 9, 2026 | Barclays | main | Overweight | Overweight |
| Sep 25, 2026 | UBS | main | Buy | Buy |
| Aug 27, 2026 | BTIG | reit | Buy | Buy |
| Aug 12, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 11, 2026 | Tigress Financial | main | Buy | Buy |
About Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- medline.com
News
- MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
- $MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
- $MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations
- MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
- Mizuho Maintains Outperform on Medline, Lowers Price Target to $45
- MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
Your note
Sign in to keep a note on MDLN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BX MOZART ML-1 HOLDCO L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 20, 2026 | 0 |
| BX MOZART ML-2 HOLDCO L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | May 27, 2026 | 0 |
| CARLYLE GROUP, INC. | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 9, 2026 | 0 |
| GIC PRIVATE LTD | Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 7, 2026 | 0 |
| HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P | Beneficial Owner of more than 10% of a Class of Security | Sale | May 27, 2026 | 0 |
| MILLS ANDREW J. | Director | Purchase | Dec 17, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Carlyle Group Inc. | 21.32% | 187,083,713 | 6.01B | Jun 29, 2026 |
| Blackstone Inc | 11.60% | 101,791,008 | 3.27B | Jun 29, 2026 |
| H&f Corporate Investors X, Ltd. | 8.08% | 70,874,326 | 2.28B | Jun 29, 2026 |
| FMR, LLC | 5.35% | 46,963,203 | 1.51B | Jun 29, 2026 |
| Capital Research Global Investors | 4.56% | 39,963,790 | 1.28B | Jun 29, 2026 |
| Invesco Ltd. | 4.37% | 38,346,937 | 1.23B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amcap Fund | 2.14% | 18,780,959 | 603.24M | Sep 29, 2026 |
| Growth Fund of America | 1.58% | 13,853,297 | 444.97M | Sep 29, 2026 |
| Fidelity Contrafund | 1.53% | 13,411,899 | 430.79M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.41% | 12,406,857 | 398.51M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 0.96% | 8,466,394 | 271.94M | Jun 29, 2026 |
| MFS SERIES TRUST I-MFS Value Fund | 0.78% | 6,853,598 | 220.14M | Aug 30, 2026 |